the hypothesis of this proposal is that autoantibodies (aab) present in Ro/SS-A (Ro) autoimmune sera are involved in the pathogenesis of LD-specific skin lesions such as SCLE and neonatal LE (NLE). Thus, characterization of the complete spectrum of aab specificities present in anti-Ro/SS-A sera is of critical importance to understanding the pathogenetic role played by the humoral autoimmune response that is seen in such patients. Previous studies have indicated that aab to native forms of calreticylin are produced in parallel to the anti-Ro/SS-A autoimmune response. In this application, the relationship that exists between these two patterns of autoimmunity will be examined, the significance of the anti-CR autoimmune response with respect to cutaneous LE will be explored, and the regulation of CR gene expression by UVB will be characterized. This will be accomplished using the following experimental approaches:
SPECIFIC AIM 1 : To Delineate the Relationship that Exists between CR and the conventional component of the Ro RNP. This will be accomplished by EMSA analysis employing CR mutants generated by the exonuclease recession technique, the SELEX technique, and the yeast two- hybrid protocol. The binding affinity of CR aab to recombinant CR-hYRNA complexes will be compared to that of recombinant CR alone.
SPECIFIC AIM 2 : to Determine the clinical and pathogenetic Significance of CR Aab in Cutaneous La patients. Various post-transnationally modified forms of rCr will be examined by ELISA and CIE for reactivity with sera from patients with cutaneous LE and disease controls. CR aab levels will be correlated with skin disease activity. The link between a-CR aab production and normal pregnancy will be further explored. The pathogenetic potential of affinity-purified anti-CR aab for triggering epidermal kerationocyte cytotoxicity will be explored.
SPECIFIC AIM 3 : To Examine the Effects of UV Radiation on the Genetic Regulation of CR. The CR gene response to UVB will be further characterized by reporter gene studies, competitive PCR, Northern blot analysis and nuclear run-on studies. The results of the studies proposed herein could provide further insights into the pathogenesis of anti-CR and anti-Ro aab-associated photosensitive Ld-specific skin diseases as well as explore the significance in cell biology of an intriguing new rheumatic disease autoantigen.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR019101-22
Application #
6171632
Study Section
Special Emphasis Panel (ZRG4-SSS-5 (03))
Program Officer
Moshell, Alan N
Project Start
1979-05-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
22
Fiscal Year
2000
Total Cost
$273,269
Indirect Cost
Name
University of Iowa
Department
Dermatology
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Sontheimer, Richard D (2005) Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4:253-63
Sontheimer, Richard D; Racila, Emil; Racila, Doina M (2005) C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 125:14-23
Sontheimer, Richard D (2004) The management of dermatomyositis: current treatment options. Expert Opin Pharmacother 5:1083-99
Ting, W; Stone, M S; Racila, D et al. (2004) Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin Lupus 13:941-50
Wu, Qiang; Fu, Yang-Xin; Sontheimer, Richard D (2004) Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft-versus-host skin disease. J Immunol 172:1630-6
Geraminejad, Pedram; DeBloom 2nd, James R; Walling, Hobart W et al. (2004) Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol 51:645-55
Sontheimer, Richard D (2004) Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol 18:429-62
Racila, D M; Sontheimer, C J; Sheffield, A et al. (2003) Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12:124-32
Sontheimer, Richard D (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387-408
Sontheimer, Richard D (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626-36

Showing the most recent 10 out of 53 publications